These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21235475)

  • 21. Development and in-vitro evaluation of a colon-specific controlled release drug delivery system.
    Talukder RM; Fassihi R
    J Pharm Pharmacol; 2008 Oct; 60(10):1297-303. PubMed ID: 18812022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-polymer mixed coating: a new approach for controlling drug release rates in pellets.
    Nisar ur Rahman ; Yuen KH; Khan NA; Wong JW
    Pharm Dev Technol; 2006 Feb; 11(1):71-7. PubMed ID: 16544910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
    Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
    Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose.
    Ohara T; Kitamura S; Kitagawa T; Terada K
    Int J Pharm; 2005 Sep; 302(1-2):95-102. PubMed ID: 16102924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting the release of nifedipine from a swellable elementary osmotic pump.
    Nokhodchi A; Momin MN; Shokri J; Shahsavari M; Rashidi PA
    Drug Deliv; 2008 Jan; 15(1):43-8. PubMed ID: 18197523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F; Jones BE
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase Transited Asymmetric Membrane Capsule: A Means for Achieving Delayed and Controlled Osmotic Flow.
    Philip AK; Philip B
    Curr Drug Deliv; 2010 Jul; 7(3):230-7. PubMed ID: 20497101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
    McConville JT; Ross AC; Florence AJ; Stevens HN
    Drug Dev Ind Pharm; 2005 Jan; 31(1):79-89. PubMed ID: 15704859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasticizer effect and comparative evaluation of cellulose acetate and ethylcellulose-HPMC combination coatings as semipermeable membranes for oral osmotic pumps of naproxen sodium.
    Ramakrishna N; Mishra B
    Drug Dev Ind Pharm; 2002 Apr; 28(4):403-12. PubMed ID: 12056533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride.
    Someshwar K; Chithaluru K; Ramarao T; Kumar KK
    Acta Pharm; 2011 Jun; 61(2):217-26. PubMed ID: 21684848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.
    Abd El-Sattar Fahmy S; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2009 Aug; 35(8):1009-21. PubMed ID: 19274589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of extended release mini-tablets using directly compressible grades of HPMC.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1690-7. PubMed ID: 23078551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation.
    Srivastava AK; Wadhwa S; Ridhurkar D; Mishra B
    Drug Dev Ind Pharm; 2005 May; 31(4-5):367-74. PubMed ID: 16093202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-unit floating alginate system: effect of additives on ciprofloxacin release.
    Srinatha A; Pandit JK
    Drug Deliv; 2008 Sep; 15(7):471-6. PubMed ID: 18712625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and development of gastroretentive drug delivery system for ofloxacin.
    Ali J; Hasan S; Ali M
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.